Breakthrough retina implant restores vision in blind patients
MassDevice - 22-Oct-2024Early trial results show restored vision in age-related macular degeneration
Join the club for FREE to access the whole archive and other member benefits.
CEO of Science and investor in Synchron
Max Hodak is the founder and Chief Technical Officer of Transcriptic. Max was inspired to form the company after working as a research assistant at Duke University Medical Center, where he built brain-machine interfaces for monkeys. As a member of the lab, he witnessed on a regular basis the inefficiencies of basic laboratory work that he felt wereripe for robotic optimization. Prior to founding Trancriptic, he was Chief Technology Officer for Inporia, where he designed software to track near-real-time price changes on e-commerce websites. He was also co-founder and CEO of MyFit, a company that designed software to forecast the likelihood of college acceptances for high school students. That company was sold to Naviance in October 2010. Max received the White House Champion of Change Award from the U.S. White House in 2013 for being a “crowdfunding pioneer” since Transcriptic was the first company to raise a seed investment round online from a crowdsourced group of angel investors. In 2015, he was named to the Forbes “30 Under 30” List in healthcare. Max received a BSE in Biomedical Engineering from Duke University.
Visit website: https://maxhodak.com/
See also: Synchron - Brain computer interface company
Details last updated 11-Feb-2022
Early trial results show restored vision in age-related macular degeneration